Another study of HNSCCs [27] demonstrated that CD166 was a valuable cell surface marker for the enrichment of HNSCC stem cells and the level of CD166 expression was associated with the tumor recurrence rate. The gene discussed is ALCAM; the disease is head and neck squamous cell carcinoma.